Senapati, J., Kantarjian, H., Kadia, T., Pemmaraju, N., DiNardo, C., Daver, N., Quesada, A., Wilson, A., Farish, K., Haddad, F., Ravandi, F., Garcia-Manero, G., Borthakur, G. (2025). Therapy related core binding factor Acute Myeloid Leukemia (CBF-AML) responds favorably to fludarabine, cytarabine, GCSF (FLAG) based therapy: Exploratory Analysis from a Phase 2 trial. Blood. https://doi.org/10.1182/blood-2025-1724